Singapore Clinical Research Institute (SCRI)

AHCC06 (SIRveNIB)                       Phase III Multi‐Centre Open‐Label Randomized Controlled Trial of Selective  Internal Radiation Therapy (SIRT) versus Sorafenib in Locally Advanced Hepatocellular Carcinoma

 AHCC05
Phase I/II Study of SIR-Spheres Plus Sorafenib as First Line Treatment in Patients With Non-Resectable Primary Hepatocellular Carcinoma

Status: Manuscript in Progress!

AHCC04
Dose escalating trial of intra-tumoral BrachySil in unresectable hepatocellular carcinoma

International Journal of Radiation Oncology *Biology*Physics Vol. 67, Issue 3, 1 March 2007; 786-792

Please click here to view the published article.

AHCC03
Randomised trial of adjuvant intra-arterial radio-active iodine after curative resection of hepatocellular carcinoma

Status: Manuscript Submission in Progress!

AHCC02  
Randomised Double-blind Trial of Megestrol Acetate vs Placebo in Treatment-naive Advanced Hepatocellular Carcinoma

Br J Cancer. 2011 September 27; 105(7): 945–952.

Please click here to view the published article.

AHCC01
Randomised trial of high-dose tamoxifen versus placebo in the treatment of inoperable hepatocellular carcinoma

Hepatology. Vol. 36 , No.5, 2002

Please click here to view the published article.